This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Chiesi Farmaceutici S.p.a., Columbia University. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2025
Title: Thomas Diacovo: Innovator in Medical Treatments
Introduction
Thomas Diacovo is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of various cancers and congenital heart diseases. With a total of 4 patents, Diacovo's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on "Compounds, compositions, and methods for treating T-cell acute lymphoblastic leukemia." This patent provides compounds and methods for administering these compounds to patients in need. Another significant patent is the "Method of preventing systemic-to-pulmonary-artery shunt thrombosis," which utilizes cangrelor for the treatment and prevention of shunt thrombosis in patients with congenital heart diseases undergoing surgery.
Career Highlights
Throughout his career, Thomas Diacovo has worked with prestigious institutions such as Columbia University and Chiesi Farmaceutici S.p.a. His research and innovations have contributed to advancements in medical treatments, particularly in oncology and cardiology.
Collaborations
Diacovo has collaborated with esteemed colleagues, including Donald W. Landry and Shi-Xian Deng. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Thomas Diacovo's innovative work in medical treatments showcases his dedication to improving patient care. His patents and collaborations reflect a commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile